BTNL2 and chronic hepatitis B virus infection: Of note, a majority of the hepatocellular carcinoma samples were obtained from patients with chronic hepatitis B virus infection (no. 1–7, 11–27), thus it is possible that BTNL2 expression in the para-cancerous tissue from these samples may not be reflective of expression in uninfected liver tissue.